WAM
TEVA icon

WealthTrust Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

WealthTrust Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$807K Sell
23,832
-615
-3% -$20.5K 0.44% 47
2026
Q1 		$736K Sell
24,447
-15,929
-39% -$512K 0.44% 44
2025
Q4 		$1.26M Sell
40,376
-2,009
-5% -$49.5K 0.88% 28
2025
Q3 		$856K Buy
+42,385
New +$744K 0.59% 39

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

WealthTrust Asset Management's TEVA Position: Q2 2026 in Review

WealthTrust Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 2.5% in Q2 2026, selling an estimated $20.5K and leaving 23,832 shares worth $807K. The position accounts for 0.44% of the portfolio, ranked #47.

WealthTrust Asset Management first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.26M in Q4 2025. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • WealthTrust Asset Management held 23,832 shares of Teva Pharmaceuticals worth $807K as of Q2 2026.
  • WealthTrust Asset Management sold 615 Teva Pharmaceuticals shares in Q2 2026, an estimated $20.5K.
  • Teva Pharmaceuticals made up 0.44% of WealthTrust Asset Management's portfolio in Q2 2026, its #47 holding.
  • WealthTrust Asset Management first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • WealthTrust Asset Management's Teva Pharmaceuticals position peaked at $1.26M in Q4 2025.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on WealthTrust Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.